Skip to main content
Erschienen in: Breast Cancer 3/2016

03.02.2015 | Original Article

Association analysis of ERCC5 gene polymorphisms with risk of breast cancer in Han women of northwest China

verfasst von: Haitao Wang, Tao Wang, Hongyun Guo, Gongjian Zhu, Suisheng Yang, Qingrong Hu, Yanze Du, Xiaorong Bai, Xuezhong Chen, Haixiang Su

Erschienen in: Breast Cancer | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

ERCC5 plays an important role in DNA damage repair. Mutations in it will lead to DNA repair defects and genomic instability. Its functional single nucleotide polymorphisms (SNPs) may alter DNA repair capacity and affect cancer susceptibility.

Methods

This study aims to evaluate the association between SNPs in ERCC5 and breast cancer susceptibility in Han women subjects genetically from northwest China. A total of 101 breast cancer patients and 101 healthy controls provided blood samples for analysis of ERCC5 rs17655 and rs751402 genotypes.

Results

After adjusting covariates, rs751402 homozygote AA and heterozygote AG were found to confer statistically significant protections (OR 0.052, 95 % CI 0.006–0.411, P = 0.005; OR 0.145, 95 % CI 0.067–0.315, P < 0.001, respectively) against breast cancer. Moreover, both of the dominant and recessive models of rs751402 also conferred a decreased risk of breast cancer (AA + AG vs. GG, OR 0.125, 95 % CI 0.060–0.261, P < 0.001; AA vs. GG + AG, OR 0.082, 95 % CI 0.010–0.648, P = 0.018, respectively).

Conclusions

The results indicate that the rs751402 in ERCC5 may affect the risk of breast cancer and show that it is associated with breast cancer characteristics in the Han population of northwest China. However, we found no significant differences between breast cancer patients and control subjects regarding ERCC5 rs17655 polymorphism in the studied population.
Literatur
1.
Zurück zum Zitat Lacey JV Jr, Devesa SS, Brinton LA. Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen. 2002;39:82–8.CrossRefPubMed Lacey JV Jr, Devesa SS, Brinton LA. Recent trends in breast cancer incidence and mortality. Environ Mol Mutagen. 2002;39:82–8.CrossRefPubMed
2.
Zurück zum Zitat Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature. 2010;468:98–102.CrossRefPubMedPubMedCentral Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospisilik JA, Lee HJ, et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature. 2010;468:98–102.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447:1087–93.CrossRefPubMedPubMedCentral Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007;447:1087–93.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Zhao E, Cui D, Yuan L, Lu W. MDM2 SNP 309 polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:3471–7.CrossRefPubMed Zhao E, Cui D, Yuan L, Lu W. MDM2 SNP 309 polymorphism and breast cancer risk: a meta-analysis. Mol Biol Rep. 2012;39:3471–7.CrossRefPubMed
5.
6.
Zurück zum Zitat Wood RD. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie. 1999;81:39–44.CrossRefPubMed Wood RD. DNA damage recognition during nucleotide excision repair in mammalian cells. Biochimie. 1999;81:39–44.CrossRefPubMed
7.
Zurück zum Zitat Wakasugi M, Reardon JT, Sancar A. The non-catalytic function of XPG protein during dual incision in human nucleotide excision repair. J Biol Chem. 1997;272:16030–4.CrossRefPubMed Wakasugi M, Reardon JT, Sancar A. The non-catalytic function of XPG protein during dual incision in human nucleotide excision repair. J Biol Chem. 1997;272:16030–4.CrossRefPubMed
8.
Zurück zum Zitat O’Donovan A, Davies AA, Moggs JG, West SC, Wood RD. XPG endonuclease makes the 3′ incision in human DNA nucleotide excision repair. Nature. 1994;371:432–5.CrossRefPubMed O’Donovan A, Davies AA, Moggs JG, West SC, Wood RD. XPG endonuclease makes the 3′ incision in human DNA nucleotide excision repair. Nature. 1994;371:432–5.CrossRefPubMed
9.
Zurück zum Zitat Emmert S, Schneider TD, Khan SG, Kraemer KH. The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms. Nucleic Acids Res. 2001;29:1443–52.CrossRefPubMedPubMedCentral Emmert S, Schneider TD, Khan SG, Kraemer KH. The human XPG gene: gene architecture, alternative splicing and single nucleotide polymorphisms. Nucleic Acids Res. 2001;29:1443–52.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hohl M, Dunand-Sauthier I, Staresincic L, Jaquier-Gubler P, Thorel F, Modesti M, et al. Domain swapping between FEN-1 and XPG defines regions in XPG that mediate nucleotide excision repair activity and substrate specificity. Nucleic Acids Res. 2007;35:3053–63.CrossRefPubMedPubMedCentral Hohl M, Dunand-Sauthier I, Staresincic L, Jaquier-Gubler P, Thorel F, Modesti M, et al. Domain swapping between FEN-1 and XPG defines regions in XPG that mediate nucleotide excision repair activity and substrate specificity. Nucleic Acids Res. 2007;35:3053–63.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Walsh CS, Ogawa S, Karahashi H, Scoles DR, Pavelka JC, Tran H, et al. ERCC5 is a novel biomarker of ovarian cancer prognosis. J Clin Oncol. 2008;26:2952–8.CrossRefPubMed Walsh CS, Ogawa S, Karahashi H, Scoles DR, Pavelka JC, Tran H, et al. ERCC5 is a novel biomarker of ovarian cancer prognosis. J Clin Oncol. 2008;26:2952–8.CrossRefPubMed
12.
Zurück zum Zitat Stevens EV, Nishizuka S, Antony S, Reimers M, Varma S, Young L, et al. Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers. Mol Cancer Ther. 2008;7:10–8.CrossRefPubMed Stevens EV, Nishizuka S, Antony S, Reimers M, Varma S, Young L, et al. Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers. Mol Cancer Ther. 2008;7:10–8.CrossRefPubMed
13.
Zurück zum Zitat Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer. 2002;94:393–7.CrossRefPubMed Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q. Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer. 2002;94:393–7.CrossRefPubMed
14.
Zurück zum Zitat Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604–8.PubMed Shen MR, Jones IM, Mohrenweiser H. Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res. 1998;58:604–8.PubMed
15.
Zurück zum Zitat Mohrenweiser HW, Xi T, Vázquez-Matías J, Jones IM. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev. 2002;11:1054–64.PubMed Mohrenweiser HW, Xi T, Vázquez-Matías J, Jones IM. Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomarkers Prev. 2002;11:1054–64.PubMed
16.
Zurück zum Zitat Bernig T, Chanock SJ. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev Mol Diagn. 2006;6:319–31.CrossRefPubMed Bernig T, Chanock SJ. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Expert Rev Mol Diagn. 2006;6:319–31.CrossRefPubMed
17.
Zurück zum Zitat Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case–control study. Int J Cancer. 2001;92:562–7.CrossRefPubMed Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case–control study. Int J Cancer. 2001;92:562–7.CrossRefPubMed
18.
Zurück zum Zitat Snoussi K, Mahfoudh W, Bouaouina N, Fekih M, Khairi H, Helal AN, et al. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer. 2010;10:283.CrossRefPubMedPubMedCentral Snoussi K, Mahfoudh W, Bouaouina N, Fekih M, Khairi H, Helal AN, et al. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer. 2010;10:283.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Blomquist TM, Crawford EL, Willey JC. Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium. Carcinogenesis. 2010;31:1242–50.CrossRefPubMedPubMedCentral Blomquist TM, Crawford EL, Willey JC. Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium. Carcinogenesis. 2010;31:1242–50.CrossRefPubMedPubMedCentral
20.
21.
Zurück zum Zitat Ding DP, He XF, Zhang Y. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case–control studies. Breast Cancer Res Treat. 2011;129:203–9.CrossRefPubMed Ding DP, He XF, Zhang Y. Lack of association between XPG Asp1104His and XPF Arg415Gln polymorphism and breast cancer risk: a meta-analysis of case–control studies. Breast Cancer Res Treat. 2011;129:203–9.CrossRefPubMed
22.
Zurück zum Zitat Cheng L, Spitz MR, Hong WK, Wei Q. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case–control analysis. Carcinogenesis. 2000;21:1527–30.CrossRefPubMed Cheng L, Spitz MR, Hong WK, Wei Q. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case–control analysis. Carcinogenesis. 2000;21:1527–30.CrossRefPubMed
23.
Zurück zum Zitat Vodicka P, Stetina R, Polakova V, Tulupova E, Naccarati A, Vodickova L, et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis. 2007;28:657–64.CrossRefPubMed Vodicka P, Stetina R, Polakova V, Tulupova E, Naccarati A, Vodickova L, et al. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis. 2007;28:657–64.CrossRefPubMed
Metadaten
Titel
Association analysis of ERCC5 gene polymorphisms with risk of breast cancer in Han women of northwest China
verfasst von
Haitao Wang
Tao Wang
Hongyun Guo
Gongjian Zhu
Suisheng Yang
Qingrong Hu
Yanze Du
Xiaorong Bai
Xuezhong Chen
Haixiang Su
Publikationsdatum
03.02.2015
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 3/2016
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-015-0590-2

Weitere Artikel der Ausgabe 3/2016

Breast Cancer 3/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.